Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-02

Clinical Trial Update: Intraperitoneal Tramadol Versus Dexmedetomedine for Analgesia After Abdominal Laparoscopic Cancer Surgeries [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial comparing intraperitoneal tramadol to dexmedetomidine for analgesia after abdominal laparoscopic cancer surgeries has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • Tramadol (tramadol)

Snippet

Sponsor: National Cancer Institute, Egypt | Conditions: Analgesia | Phase 2, Phase 3 | Status: COMPLETED